selective inhibitorscolorectal cancernon-small cell lung cancerpancreatic ductal adenocarcinomaPDACstandard therapies
…andard therapies.2 Despite the very much awaited development of selective inhibitors targeting mutant RAS, these have unfortunately been confronted …